BIOMAT Database Logo BIOMAT Database Logo

Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. 2002

Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
The University of Illinois at Chicago, Department of Pharmacy Practice, Chicago, IL, USA. Pendland@uic.edu

The influence of bacterial strain and antibiotic concentration on the time to achieve in vitro bactericidal activity was determined for gatifloxacin and ciprofloxacin using time-kill methodology. Killing rates were significantly affected by bacterial strain, antibiotic concentration, and type of fluoroquinolone. The most rapid bactericidal activity was seen against members of the Enterobacteriaceae and with fluoroquinolone concentrations of 8-16 X MIC. In general, gatifloxacin demonstrated faster killing against Acinetobacter baumanii, Legionella pneumophila, Staphylococcus aureus, and Streptococcus pneumoniae.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077734 Gatifloxacin A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. 1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,AM 1155,AM-1155,BMS-206584,CG 5501,Gatifloxacine,Tequin,Zymar,BMS 206584,BMS206584
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.
December 2000, International journal of antimicrobial agents,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.
March 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
January 1993, Microbios,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
May 1986, The Journal of antimicrobial chemotherapy,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
July 2002, Chemotherapy,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
January 1990, Drugs under experimental and clinical research,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Post-antibiotic effect and killing activity of ciprofloxacin against Staphylococcus aureus.
June 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates.
June 1999, Diagnostic microbiology and infectious disease,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
April 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Susan L Pendland, and Melinda M Neuhauser, and Kevin W Garey, and Jennifer L Prause, and Rose Jung
Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria.
November 2001, Diagnostic microbiology and infectious disease,
Copied contents to your clipboard!